In vivo validation and characterization of allelic variants in lupus identification and characterization of the etiologic and pathogenic mechanisms underlying systemic lupus erythematosus (SLE) are paramount for prevention and treatment of disease and one of its most mortal complications, glomerulonephritis. With the advent of whole genome sequencing came tantalizing allelic variants in patients with systemic lupus erythematosus (SLE);however, a critical barrier to understanding the role of these variants is that their characterization has been limited in vivo, especially in well-characterized mouse models of lupus nephritis. Furthermore, few data exist regarding allelic variants in lupus glomerulonephritis specifically. The goals of this work will be to (1) overcome a critical barrier n the field by creation of an in vivo system of lupus nephritis-prone mice harboring an immune system expressing allelic variants or their respective short hairpin RNA (shRNA) and (2) characterize the effects of allelic variants on disease progression. These studies will provide insight into allelic variants in patients with lupus nephritis and provide even broader impact on the field of autoimmunity as a whole.
Understanding what causes systemic lupus erythematosus (SLE) is paramount for prevention and treatment of the disease and one of its most mortal complications, glomerulonephritis. With the advent of whole genome sequencing came the realization that certain genes are mutated in patients with SLE;however, examination of the result of these mutations on the disease process has been limited. These studies will provide insight into the function of these mutated genes in patients with lupus nephritis and provide even broader impact on the field of autoimmunity as a whole.
|Pendergraft 3rd, William F; Badhwar, Anshul K; Preston, Gloria A (2015) Autoantigen complementarity and its contributions to hallmarks of autoimmune disease. J Theor Biol 375:88-94|
|Ramirez-Ortiz, Zaida G; Prasad, Amit; Griffith, Jason W et al. (2015) The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity. Nat Immunol 16:495-504|
|Pendergraft 3rd, William F; Nachman, Patrick H (2015) Recent pathogenetic advances in ANCA-associated vasculitis. Presse Med 44:e223-9|
|Schober, Fernanda Payan; Pendergraft 3rd, William F (2015) Dialogue: A blissful future for lupus nephritis: harnessing repeat kidney biopsies to identify meaningful biomarkers of disease. Lupus Sci Med 2:e000083|
|Pendergraft 3rd, William F; Herlitz, Leal C; Thornley-Brown, Denyse et al. (2014) Nephrotoxic effects of common and emerging drugs of abuse. Clin J Am Soc Nephrol 9:1996-2005|
|Pendergraft 3rd, William F; Niles, John L (2014) Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26:42-9|
|Arazi, Arnon; Pendergraft 3rd, William F; Ribeiro, Ruy M et al. (2013) Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches. Semin Immunol 25:193-200|
|Ramirez-Ortiz, Zaida G; Pendergraft 3rd, William F; Prasad, Amit et al. (2013) The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat Immunol 14:917-26|